Section Arrow
ICUI.NASDAQ
- ICU Medical
Quotes are at least 15-min delayed:2025/09/17 08:23 EDT
Pre Market
Last
 129.99
-0.37 (-0.28%)
Bid
105
Ask
208.57
High 129.99 
Low 129.99 
Volume
Regular Hours
Last
 130.36
-1.81 (-1.37%)
Day High 
131.94 
Prev. Close
132.17 
1-M High
136.61 
Volume 
344.11K 
Bid
105
Ask
208.57
Day Low
128.7 
Open
131.66 
1-M Low
120.41 
Market Cap 
3.26B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 130.03 
20-SMA 127.67 
50-SMA 126.32 
52-W High 196.2607 
52-W Low 107 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.52/8.40
Enterprise Value
4.84B
Balance Sheet
Book Value Per Share
85.71
Cash Flow
Cash Flow Yield
0.04
Income Statement
Total Revenue
1.32B
Operating Revenue Per Share
91.12
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BNGOBionano Genomics Inc1.78-0.99-35.74%0.02PE
Pre Market 1.7503 -0.0297 -1.67%
HBIOHarvard Bioscience0.4849+0.0454+10.33%-- 
Pre Market 0.4557 -0.0292 -6.02%
AVTRAvantor12.71+0.32+2.58%12.27PE
Pre Market 12.81 +0.1 +0.79%
BAXBaxter International23.87+0.07+0.29%140.32PE
Pre Market 23.9523 +0.0823 +0.34%
MBOTMicrobot Medical3.34-0.08-2.34%-- 
Pre Market 3.3412 +0.0012 +0.04%
Quotes are at least 15-min delayed:2025/09/17 08:23 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems(28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.